Advertisement Roche launches new co-pay program in Pennsylvania - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Roche launches new co-pay program in Pennsylvania

Roche has launched its new eVoucherRx pilot program in Pennsylvania, designed to make it easier for patients with diabetes to receive their co-pay savings on Accu-Chek test strips.

The program, active now at participating pharmacies, ensures patients with diabetes that their co-pay for Accu-Chek test strips will not exceed $25. The program provides a discount of up to $40 per month, potentially lowering a patient’s cost of blood glucose monitoring supplies by up to $480 per year.

According to Roche, eVoucherRx is a program that works in real time at the point of dispensing, which means patients do not need to do anything other than go to a participating pharmacy.

The eVoucherRx program is administered by RelayHealth for patients with commercial third-party health insurance. The program is not open to patients age 65 or older, cash-paying customers, patients on Medicare, Medicaid or those subsidized by other government-funded plans.

Dan Kane, vice president of marketing at Roche, said: “eVoucherRx also helps prescribing physicians know that more of their patients will be able to afford their diabetes supplies. Our program means less cost to our patients, it’s seamless and hassle-free and it should lead to better health outcomes.”